17297424

Source:http://linkedlifedata.com/resource/pubmed/id/17297424

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017296, umls-concept:C0345904
pubmed:issue	1
pubmed:dateCreated	2007-2-13
pubmed:abstractText	Gene therapy of liver cancer covers a variety of gene transfer strategies aimed to the treatment of patients with primary and secondary liver tumors, including gene directed enzyme/pro-drug therapy, inhibition of oncogenes and restoration of tumor-suppressor genes, immunotherapy, anti-angiogenesis and virotherapy. Some of these strategies have reached early clinical development with diverse little success.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101155885
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	1665-2681
pubmed:author	pubmed-author:Hernández-AlcocebaRubénR, pubmed-author:PrietoJesúsJ, pubmed-author:SangroBrunoB
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5-14
pubmed:meshHeading	pubmed-meshheading:17297424-Carcinoma, Hepatocellular, pubmed-meshheading:17297424-Gene Therapy, pubmed-meshheading:17297424-Humans, pubmed-meshheading:17297424-Liver Neoplasms, pubmed-meshheading:17297424-Treatment Outcome
pubmed:articleTitle	Gene therapy of liver cancer.
pubmed:affiliation	Division of Gene Therapy and Hepatology, Foundation for Applied Medical Research-CIMA, University of Navarra, Pamplona, Spain.
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't